Loading organizations...
Loading organizations...
Drug discovery for CNS diseases using cellular connectome mapping.
Violet Therapeutics has raised $10.6M across 1 funding round.
Violet Therapeutics has raised $10.6M in total across 1 funding round.
Violet Therapeutics has raised $10.6M in total across 1 funding round.
Violet Therapeutics's investors include Jonathan Behr, Atsushi Usami, Meredith Fisher, Shunichiro Matsumoto.
Violet Therapeutics has raised $10.6M across 1 funding round. Most recently, it raised $10.6M Seed in June 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 2, 2023 | $10.6M Seed | Jonathan Behr, Atsushi Usami | Meredith Fisher, Shunichiro Matsumoto |